LCN2 can modulate the apoptotic process by interacting with interleukin-3 (IL-3) and IL-8 to influence tumor progression, metastasis, and prognosis in FL5.12 cells, endometrial cancer, and liver cancer [4, 18, 19]. Here, IL3 is linked to neoplasm.